Don't Think of A1C Goals as "One-Size-Fits-All"

April 2018

Controversy is brewing about how to individualize A1C goals for adults with type 2 diabetes...due to conflicting guidelines.

Many of us were taught to aim for an A1C under 7% to reduce MICROvascular complications...retinopathy, nephropathy, and neuropathy.

But lowering A1C doesn't seem to reduce MACROvascular events...MI or stroke...and doesn't decrease risk of death.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Diabetes Don't Think of A1C Goals as "One-Size-Fits-All"
Vaccines Resolve Common Questions About Shingrix Administration
Cardiology Manage New Warnings About Clarithromycin and Cardiovascular Risk
Infectious Diseases Lean Toward Oral Vancomycin for Initial Treatment of C. diff Diarrhea
Fentanyl Patches Follow Safeguards When Prescribing Fentanyl Patches
Rheumatoid Arthritis Consider Using Subcutaneous Methotrexate More for Rheumatoid Arthritis
Cannabinoids Know How the Rx Cannabinoids Compare
Men's Health Consider if Meds or Supplements May Be Contributing to Male Infertility
Asthma Close the Gap in Asthma Care in Kids
Aspirin Be Prepared With the Latest Answers About Aspirin
Insulin Watch for New "Follow-On" Mealtime Insulin Admelog (Lispro)